California AB687 mandates no cost sharing for colorectal cancer screenings approved by the FDA or recommended by the U.S.

California AB687 amends the Insurance Code and Health and Safety Code to require health care service plans and health insurance policies to cover colorectal cancer screenings without cost sharing. These screenings must be approved by the FDA, meet federal coverage requirements, or be recommended by the U.S. Preventive Services Task Force. The bill also covers required colonoscopies for positive screening results. This provision is set to remain in effect until January 1, 2031, after which it will be repealed.

California AB687 mandates no cost sharing for colorectal cancer screenings approved by the FDA or recommended by the U.S.

California AB687 amends the Insurance Code and Health and Safety Code to require health care service plans and health insurance policies to cover colorectal cancer screenings without cost sharing. These screenings must be approved by the FDA, meet federal coverage requirements, or be recommended by the U.S. Preventive Services Task Force. The bill also covers required colonoscopies for positive screening results. This provision is set to remain in effect until January 1, 2031, after which it will be repealed.